Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling

Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2016-04, Vol.247, p.207-217
Hauptverfasser: Fetterman, Jessica L, Holbrook, Monica, Flint, Nir, Feng, Bihua, Bretόn-Romero, Rosa, Linder, Erika A, Berk, Brittany D, Duess, Mai-Ann, Farb, Melissa G, Gokce, Noyan, Shirihai, Orian S, Hamburg, Naomi M, Vita, Joseph A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 217
container_issue
container_start_page 207
container_title Atherosclerosis
container_volume 247
creator Fetterman, Jessica L
Holbrook, Monica
Flint, Nir
Feng, Bihua
Bretόn-Romero, Rosa
Linder, Erika A
Berk, Brittany D
Duess, Mai-Ann
Farb, Melissa G
Gokce, Noyan
Shirihai, Orian S
Hamburg, Naomi M
Vita, Joseph A
description Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.
doi_str_mv 10.1016/j.atherosclerosis.2016.01.043
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4913892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915016300429</els_id><sourcerecordid>1776086313</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEotvCX0C-IHFJGH9sNjlQCVXQIlVC4uNsOc5kd5YkDrazZf89jrZU0BMXj2S_8-H3mSx7zaHgwMu3-8LEHXoXbL-cFAqRrgvgBSj5JFvxalPnXFXqabYCEDyv-RrOsvMQ9gCgNrx6np2JshZlCXyV-S8YovMmkhuZ65iZo5t2ZntkNDIcW5ea9WR6ZrHvA-u8G9iU1DjGwO4o7lhLpsGIgQ1JQXEOjIbJu0O6GSl6ssz9ohZZoO1oehq3L7JnnekDvryPF9n3jx--Xd3kt5-vP129v83teq1iXqsUSiWksZWoDCCWDVQtAhe1QTAKpAFlpbRd04m64l0jSwmA1brulOXyIrs81Z3mZsDWppG96fXkaTD-qJ0h_e_LSDu9dQetai6rWqQCb-4LePdzTj7pgcLigxnRzUHzzaaEqpRcJum7k9QmJsFj99CGg1646b1-xE0v3DRwnbil_Fd_z_qQ_QdUElyfBJgcOxB6HWyCYLEljzbq1tF_t7p8VMkmKmRN_wOPGPZu9olT-p0OQoP-uizRskN8MVeJWv4GYcTMRw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776086313</pqid></control><display><type>article</type><title>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fetterman, Jessica L ; Holbrook, Monica ; Flint, Nir ; Feng, Bihua ; Bretόn-Romero, Rosa ; Linder, Erika A ; Berk, Brittany D ; Duess, Mai-Ann ; Farb, Melissa G ; Gokce, Noyan ; Shirihai, Orian S ; Hamburg, Naomi M ; Vita, Joseph A</creator><creatorcontrib>Fetterman, Jessica L ; Holbrook, Monica ; Flint, Nir ; Feng, Bihua ; Bretόn-Romero, Rosa ; Linder, Erika A ; Berk, Brittany D ; Duess, Mai-Ann ; Farb, Melissa G ; Gokce, Noyan ; Shirihai, Orian S ; Hamburg, Naomi M ; Vita, Joseph A</creatorcontrib><description>Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2016.01.043</identifier><identifier>PMID: 26926601</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adenosine - analogs &amp; derivatives ; Adenosine - pharmacology ; Adult ; Aged ; Autophagy ; Autophagy - drug effects ; Biomarkers - metabolism ; Cardiovascular ; Case-Control Studies ; Cell Separation - methods ; Cells, Cultured ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - pathology ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetic Angiopathies - blood ; Diabetic Angiopathies - pathology ; Diabetic Angiopathies - physiopathology ; Diabetic Angiopathies - prevention &amp; control ; Endothelial cells ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Female ; Humans ; Macrolides - pharmacology ; Male ; Middle Aged ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - metabolism ; Signal Transduction - drug effects ; Spermidine - pharmacology</subject><ispartof>Atherosclerosis, 2016-04, Vol.247, p.207-217</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2016 Elsevier Ireland Ltd</rights><rights>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</citedby><cites>FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</cites><orcidid>0000-0002-9981-288X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021915016300429$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26926601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fetterman, Jessica L</creatorcontrib><creatorcontrib>Holbrook, Monica</creatorcontrib><creatorcontrib>Flint, Nir</creatorcontrib><creatorcontrib>Feng, Bihua</creatorcontrib><creatorcontrib>Bretόn-Romero, Rosa</creatorcontrib><creatorcontrib>Linder, Erika A</creatorcontrib><creatorcontrib>Berk, Brittany D</creatorcontrib><creatorcontrib>Duess, Mai-Ann</creatorcontrib><creatorcontrib>Farb, Melissa G</creatorcontrib><creatorcontrib>Gokce, Noyan</creatorcontrib><creatorcontrib>Shirihai, Orian S</creatorcontrib><creatorcontrib>Hamburg, Naomi M</creatorcontrib><creatorcontrib>Vita, Joseph A</creatorcontrib><title>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.</description><subject>Adenosine - analogs &amp; derivatives</subject><subject>Adenosine - pharmacology</subject><subject>Adult</subject><subject>Aged</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>Biomarkers - metabolism</subject><subject>Cardiovascular</subject><subject>Case-Control Studies</subject><subject>Cell Separation - methods</subject><subject>Cells, Cultured</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetic Angiopathies - blood</subject><subject>Diabetic Angiopathies - pathology</subject><subject>Diabetic Angiopathies - physiopathology</subject><subject>Diabetic Angiopathies - prevention &amp; control</subject><subject>Endothelial cells</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Macrolides - pharmacology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Spermidine - pharmacology</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEotvCX0C-IHFJGH9sNjlQCVXQIlVC4uNsOc5kd5YkDrazZf89jrZU0BMXj2S_8-H3mSx7zaHgwMu3-8LEHXoXbL-cFAqRrgvgBSj5JFvxalPnXFXqabYCEDyv-RrOsvMQ9gCgNrx6np2JshZlCXyV-S8YovMmkhuZ65iZo5t2ZntkNDIcW5ea9WR6ZrHvA-u8G9iU1DjGwO4o7lhLpsGIgQ1JQXEOjIbJu0O6GSl6ssz9ohZZoO1oehq3L7JnnekDvryPF9n3jx--Xd3kt5-vP129v83teq1iXqsUSiWksZWoDCCWDVQtAhe1QTAKpAFlpbRd04m64l0jSwmA1brulOXyIrs81Z3mZsDWppG96fXkaTD-qJ0h_e_LSDu9dQetai6rWqQCb-4LePdzTj7pgcLigxnRzUHzzaaEqpRcJum7k9QmJsFj99CGg1646b1-xE0v3DRwnbil_Fd_z_qQ_QdUElyfBJgcOxB6HWyCYLEljzbq1tF_t7p8VMkmKmRN_wOPGPZu9olT-p0OQoP-uizRskN8MVeJWv4GYcTMRw</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Fetterman, Jessica L</creator><creator>Holbrook, Monica</creator><creator>Flint, Nir</creator><creator>Feng, Bihua</creator><creator>Bretόn-Romero, Rosa</creator><creator>Linder, Erika A</creator><creator>Berk, Brittany D</creator><creator>Duess, Mai-Ann</creator><creator>Farb, Melissa G</creator><creator>Gokce, Noyan</creator><creator>Shirihai, Orian S</creator><creator>Hamburg, Naomi M</creator><creator>Vita, Joseph A</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9981-288X</orcidid></search><sort><creationdate>20160401</creationdate><title>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</title><author>Fetterman, Jessica L ; Holbrook, Monica ; Flint, Nir ; Feng, Bihua ; Bretόn-Romero, Rosa ; Linder, Erika A ; Berk, Brittany D ; Duess, Mai-Ann ; Farb, Melissa G ; Gokce, Noyan ; Shirihai, Orian S ; Hamburg, Naomi M ; Vita, Joseph A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-945546423ac828a0ee6b08de0129ae0a403a04c33cfbf2981fb36300e859f4c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adenosine - analogs &amp; derivatives</topic><topic>Adenosine - pharmacology</topic><topic>Adult</topic><topic>Aged</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>Biomarkers - metabolism</topic><topic>Cardiovascular</topic><topic>Case-Control Studies</topic><topic>Cell Separation - methods</topic><topic>Cells, Cultured</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetic Angiopathies - blood</topic><topic>Diabetic Angiopathies - pathology</topic><topic>Diabetic Angiopathies - physiopathology</topic><topic>Diabetic Angiopathies - prevention &amp; control</topic><topic>Endothelial cells</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Macrolides - pharmacology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Spermidine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fetterman, Jessica L</creatorcontrib><creatorcontrib>Holbrook, Monica</creatorcontrib><creatorcontrib>Flint, Nir</creatorcontrib><creatorcontrib>Feng, Bihua</creatorcontrib><creatorcontrib>Bretόn-Romero, Rosa</creatorcontrib><creatorcontrib>Linder, Erika A</creatorcontrib><creatorcontrib>Berk, Brittany D</creatorcontrib><creatorcontrib>Duess, Mai-Ann</creatorcontrib><creatorcontrib>Farb, Melissa G</creatorcontrib><creatorcontrib>Gokce, Noyan</creatorcontrib><creatorcontrib>Shirihai, Orian S</creatorcontrib><creatorcontrib>Hamburg, Naomi M</creatorcontrib><creatorcontrib>Vita, Joseph A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fetterman, Jessica L</au><au>Holbrook, Monica</au><au>Flint, Nir</au><au>Feng, Bihua</au><au>Bretόn-Romero, Rosa</au><au>Linder, Erika A</au><au>Berk, Brittany D</au><au>Duess, Mai-Ann</au><au>Farb, Melissa G</au><au>Gokce, Noyan</au><au>Shirihai, Orian S</au><au>Hamburg, Naomi M</au><au>Vita, Joseph A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>247</volume><spage>207</spage><epage>217</epage><pages>207-217</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Abstract Background Endothelial dysfunction contributes to cardiovascular disease in diabetes mellitus. Autophagy is a multistep mechanism for the removal of damaged proteins and organelles from the cell. Under diabetic conditions, inadequate autophagy promotes cellular dysfunction and insulin resistance in non-vascular tissue. We hypothesized that impaired autophagy contributes to endothelial dysfunction in diabetes mellitus. Methods and results We measured autophagy markers and endothelial nitric oxide synthase (eNOS) activation in freshly isolated endothelial cells from diabetic subjects (n = 45) and non-diabetic controls (n = 41). p62 levels were higher in cells from diabetics (34.2 ± 3.6 vs. 20.0 ± 1.6, P = 0.001), indicating reduced autophagic flux. Bafilomycin inhibited insulin-induced activation of eNOS (64.7 ± 22% to −47.8 ± 8%, P = 0.04) in cells from controls, confirming that intact autophagy is necessary for eNOS signaling. In endothelial cells from diabetics, activation of autophagy with spermidine restored eNOS activation, suggesting that impaired autophagy contributes to endothelial dysfunction (P = 0.01). Indicators of autophagy initiation including the number of LC3-bound puncta and beclin 1 expression were similar in diabetics and controls, whereas an autophagy terminal phase indicator, the lysosomal protein Lamp2a, was higher in diabetics. In endothelial cells under diabetic conditions, the beneficial effect of spermidine on eNOS activation was blocked by autophagy inhibitors bafilomycin or 3-methyladenine. Blocking the terminal stage of autophagy with bafilomycin increased p62 (P = 0.01) in cells from diabetics to a lesser extent than in cells from controls (P = 0.04), suggesting ongoing, but inadequate autophagic clearance. Conclusion Inadequate autophagy contributes to endothelial dysfunction in patients with diabetes and may be a target for therapy of diabetic vascular disease.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>26926601</pmid><doi>10.1016/j.atherosclerosis.2016.01.043</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9981-288X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 2016-04, Vol.247, p.207-217
issn 0021-9150
1879-1484
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4913892
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenosine - analogs & derivatives
Adenosine - pharmacology
Adult
Aged
Autophagy
Autophagy - drug effects
Biomarkers - metabolism
Cardiovascular
Case-Control Studies
Cell Separation - methods
Cells, Cultured
Diabetes mellitus
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - pathology
Diabetes Mellitus, Type 2 - physiopathology
Diabetic Angiopathies - blood
Diabetic Angiopathies - pathology
Diabetic Angiopathies - physiopathology
Diabetic Angiopathies - prevention & control
Endothelial cells
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Endothelial Cells - pathology
Female
Humans
Macrolides - pharmacology
Male
Middle Aged
Nitric Oxide - metabolism
Nitric Oxide Synthase Type III - metabolism
Signal Transduction - drug effects
Spermidine - pharmacology
title Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A09%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Restoration%20of%20autophagy%20in%20endothelial%20cells%20from%20patients%20with%20diabetes%20mellitus%20improves%20nitric%20oxide%20signaling&rft.jtitle=Atherosclerosis&rft.au=Fetterman,%20Jessica%20L&rft.date=2016-04-01&rft.volume=247&rft.spage=207&rft.epage=217&rft.pages=207-217&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2016.01.043&rft_dat=%3Cproquest_pubme%3E1776086313%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776086313&rft_id=info:pmid/26926601&rft_els_id=S0021915016300429&rfr_iscdi=true